United States · Who invested in Variant Pharmaceuticals?
Variant Pharmaceuticals's investors include Incon.
2015201620172018
$3.0MVenture$10MRoundUnited States · Funded startup
Who invested in Variant Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$13Mraised across 2 rounds since 2015, from 2 sources
$3.0MVenture$10MRound
- Latest round
- Round, $10MDec 2018
- Step-upi
- 3.4×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $3.0M Feb 2015
- Biggest round
- $10M Round · Dec 2018
- Between rounds
- 3.8 years from the last two
The rounds
- Dec 2018
- Feb 2015Venture$3.0M
No investor was named in the report.
From a historical funding recordSEC filing: $3.0M sold, first sale Jul 2014
Founders and team
From Variant Pharmaceuticals's own website and the SEC filings it signed: 1 founder, 2 on the team.
Stephen C. GloverCo-founder, Chairman, CEO, and PresidentNamed on its 2018 Form D
- Karen CashmereChief Commercial Officer
- Peter WolfeChief Financial Officer
On the board, as filediAaron C GreenblattJules C Musing
Quick answers about Variant Pharmaceuticals
How much has Variant Pharmaceuticals raised?
Variant Pharmaceuticals has raised $13M across 2 rounds since 2015.
When did Variant Pharmaceuticals last raise?
Variant Pharmaceuticals's most recent round was an Undisclosed round of $10M in Dec 2018.
What was Variant Pharmaceuticals's biggest round?
Its most recent round, $10M in Dec 2018, is also its largest on record.
Who backed Variant Pharmaceuticals first?
Variant Pharmaceuticals's first round on record, in Dec 2018, was backed by Incon.
What stage is Variant Pharmaceuticals at?
Variant Pharmaceuticals's latest named round is an Undisclosed round, in Dec 2018.
Where is Variant Pharmaceuticals based?
Variant Pharmaceuticals is based in the United States.
Companies like Variant Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.